Aug 07, 2025
104:41
For every 41 shares held, investors received 104. The price per share adjusted from $2.80 to $1.10.
The split itself did not change the total investment value.
Modus Therapeutics Holding AB (STO:MODTX) operates in the Biotechnology industry.
Modus Therapeutics Holding AB company overviewModus Therapeutics Holding AB's most recent stock split was on August 7, 2025. It was a 104-for-41 forward split, so shareholders received 104 shares for every 41 they held.
Modus Therapeutics Holding AB has split its stock once. This history records one forward split, on August 7, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Modus Therapeutics Holding AB's 104-for-41 split on August 7, 2025, every 41 shares became 104 shares.
Modus Therapeutics Holding AB has not announced a new split in our records. Its most recent split was on August 7, 2025, 1 year ago. Companies announce splits in advance, and any new STO:MODTX split will appear on this page.
Already premium?